Market Insights Health Pharmaceuticals Vaccines

COVID-19 Vaccines - Tunisia

Tunisia

The COVID-19 Vaccines market in Tunisia is expected to witness significant growth in the coming years.
By 2024, the projected revenue is estimated to reach US$15.52m in Tunisia.
Furthermore, it is anticipated that the market will experience a steady annual growth rate of -18.39% from 2024 to 2029, resulting in a market volume of US$5.62m by 2029.
When compared globally, United States is expected to generate the highest revenue in the COVID-19 Vaccines market.
In 2024, the projected revenue for the United States is estimated to be US$4,389,000.00k.
Tunisia's COVID-19 vaccine market is experiencing a surge in demand due to the government's proactive vaccination campaign and the population's eagerness to protect themselves.

Key regions: United Kingdom, Germany, France, South Korea, Italy

Market

Region

Region comparison

Currency

Analyst Opinion

The COVID-19 pandemic has had a significant impact on the global healthcare industry, with the vaccines market being one of the most affected. In Tunisia, the COVID-19 vaccines market has been developing at a steady pace, driven by various factors.

Customer preferences: Customers in Tunisia have shown a high level of interest in COVID-19 vaccines, with many individuals eager to get vaccinated as soon as possible. This is largely due to the severity of the pandemic in the country, which has resulted in a large number of cases and deaths. Additionally, the Tunisian government has been actively promoting the importance of vaccination, which has helped to increase public awareness and acceptance of the vaccines.

Trends in the market: One of the key trends in the COVID-19 vaccines market in Tunisia is the growing popularity of mRNA vaccines, such as Pfizer-BioNTech and Moderna. These vaccines have been shown to be highly effective against the virus, and have been widely used in other countries. Another trend is the increasing availability of vaccines, with more doses being distributed to healthcare facilities across the country. This has helped to increase the number of people who have been vaccinated, and has also led to a reduction in the number of COVID-19 cases.

Local special circumstances: Tunisia has a unique set of circumstances that have influenced the development of the COVID-19 vaccines market. One of the main factors is the country's relatively low GDP per capita, which has limited the government's ability to purchase large quantities of vaccines. This has resulted in a slower rollout of vaccines compared to other countries, and has also led to some shortages in certain areas. Additionally, Tunisia has a large population of refugees and migrants, which has presented logistical challenges in terms of vaccine distribution and administration.

Underlying macroeconomic factors: The COVID-19 vaccines market in Tunisia is also influenced by a range of macroeconomic factors. One of the most significant is the country's high level of public debt, which has limited the government's ability to invest in healthcare infrastructure and vaccine procurement. Additionally, Tunisia has been struggling with high levels of unemployment and inflation, which has made it difficult for many people to afford healthcare services, including vaccinations. Despite these challenges, the COVID-19 vaccines market in Tunisia is expected to continue to grow in the coming years, driven by increasing demand and the availability of new vaccines.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.